# AIBOTICS, INC. (AIBT) · Edgar & Edgarette company card

> Aibotics (AIBT) reported revenue of $0 million in FY2025, operating margin -84502% against a 0.7% median for medicinal chemicals & botanical products, equity -453% of assets. Every figure is from the company’s own annual report filed with the SEC.

SEC CIK 1763329 · fiscal year ended 2025-12-31 · 4 audited years read · [page](https://www.pops4.com/boards/company/AIBT) · [JSON](https://www.pops4.com/boards/company/AIBT.json)

## Figures, as filed in the 10-K

| Measure | Value |
|---|---|
| Revenue | $2,183 |
| Revenue growth, 1 year | — |
| Revenue growth per year | — |
| Operating margin | -84501.7% (prior year -Infinity%) |
| Net margin | -101500.3% |
| Operating cash flow | −$458,240 |
| Capital spending | — |
| Free cash flow | — |
| Cash | $255,940 |
| Long-term debt | — |
| Total assets | $874,673 |
| Total equity | −$4M |
| Equity ÷ assets | -452.8% |
| Return on equity | — |
| Dividend per share | — |
| Dividend years rising | — |

## Readings, computed from those figures

- Altman Z: -97.51 (distress zone)
- Piotroski F: 4 of 9 (middling)
- Health Harbor boat: Rotting at the dock · four or more warning signs · filed late annual report notice, late quarterly report notice in the last 12 months; liabilities exceed assets (often from years of share buybacks, not always distress); operating cash flow was negative (-$458K in FY2025); operating loss: a margin of -84501.7% in FY2025

## Edgarette's reading

Exposure: revenue $2K (FY2025). Experience: one year on record; operating margin -84501.7%, up from null. Soundness: equity -452.8% of assets (liabilities exceed assets). Credibility: four or more audited years, reasonable weight. Against peers (10 filers, $50M+ revenue, medicinal chemicals & botanical products): operating margin -84501.7% against a 0.7% median.

## Health Watch, last 12 months

- Item NT 10-K Late annual report notice: 1, latest 2026-03-31 ([filing](https://www.sec.gov/Archives/edgar/data/1763329/000109690626000443/0001096906-26-000443-index.htm))
- Item NT 10-Q Late quarterly report notice: 3, latest 2026-11-16 ([filing](https://www.sec.gov/Archives/edgar/data/1763329/000109690626001790/0001096906-26-001790-index.htm))

## Recent filings

- 8-K · filed 2026-10-16 · 1.01 Entry into a Material Definitive Agreement; 2.01 Completion of Acquisition or Disposition of Assets; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1763329/000109690626001565/0001096906-26-001565-index.htm)
- 8-K · filed 2026-10-05 · 1.01 Entry into a Material Definitive Agreement; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1763329/000109690626001500/0001096906-26-001500-index.htm)
- 10-Q · filed 2026-08-19 · [filing](https://www.sec.gov/Archives/edgar/data/1763329/000109690626001264/0001096906-26-001264-index.htm)
- 10-Q · filed 2026-06-09 · [filing](https://www.sec.gov/Archives/edgar/data/1763329/000109690626000922/0001096906-26-000922-index.htm)
- 10-K · filed 2026-04-15 · [filing](https://www.sec.gov/Archives/edgar/data/1763329/000109690626000555/0001096906-26-000555-index.htm)
- 10-Q · filed 2025-11-19 · [filing](https://www.sec.gov/Archives/edgar/data/1763329/000109690625001895/0001096906-25-001895-index.htm)

## Sources

- facts: https://data.sec.gov/api/xbrl/companyfacts/CIK0001763329.json
- filings: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1763329

## Cite

POPS4, Edgar & Edgarette: AIBOTICS, INC. (AIBT) company card, from the company's own SEC filings, accessed 2026-11-19, https://www.pops4.com/boards/company/AIBT. CC BY 4.0. For a figure, add the filing URL under filings or sources.

DOI https://doi.org/10.5281/zenodo.23672509 · catalog https://www.pops4.com/boards/catalog.json · Figures as filed with the SEC. Card text CC BY 4.0, POPS4.

Reporting, not investment advice. No price targets and no trading recommendations.

Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price.

